Contact Us

Baycol
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?

Has Rhabdomyolysis been diagnosed?

Have any of the following side effects occurred?







Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Bayer's filings with SEC reveal two subpoenas

Mar 8, 2006 | Pittsburgh Post-Gazette

Bayer AG disclosed in filings with the Securities and Exchange Commission that it received subpoenas in two separate cases.

The German-based drug and chemicals firm was subpoenaed by the Department of Justice last month in connection with alleged price-fixing of plastics products. Bayer said it was a defendant in multiple class-action lawsuits that have been consolidated in federal court in Kansas.

Separately, the company was subpoenaed by the U.S. attorney in New Jersey in connection with an earlier federal subpoena over its withdrawn cholesterol drug, Baycol.

Bayer said in the SEC filings that it had exhausted its insurance coverage and could be subject to further payments in 5,900 pending suits that involve Baycol.


Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo